-
-
-
-
-
-
-
Theriva Biologics (TOVX) Misses Q1 EPS by 155c
-
-
-
-
-
-
-
Theriva Biologics (TOVX) Announces Positive Outcome of Data and Safety Monitoring Committee Review in Phase 1b/2a Trial of SYN-004
-
-
-
-
-
-
430,621 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

